Herantis Pharma Oyj financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2013 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
0.00€M | 0.00€M | 0.03€M | 0.00€M | 0.00€M | 0.00€M | 0.09€M | 0.00€M | 0.00€M | 0.00€M | 0.00€M | 0.00€M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | -7.11% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00€ | |||||||||||
| Div. | Dividends |
|
0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ | 0.00€ |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
4.06m | 4.09m | 4.12m | 4.92m | 4.92m | 6.68m | 7.59m | 9.76m | 0m | 12.08m | 20.16m | 20.16m |
| OCF | Operating Cash Flow |
|
-4.36€M | -7.40€M | -3.04€M | -2.60€M | -3.73€M | -5.96€M | -8.56€M | -9.93€M | -0.22€M | -8.94€M | -4.64€M | 0.00€M |
| FCF | Free Cash Flow |
|
-4.37€M | -7.41€M | -3.05€M | 0.00€M | 0.00€M | -5.96€M | -8.56€M | 0.00€M | 0.00€M | -9.15€M | -2.00€M | 0.00€M |
| FCFS | Free Cash Flow Per Share |
|
-1.68€ | -1.82€ | -0.74€ | -0.62€ | -0.76€ | -1.02€ | -1.16€ | -0.97€ | -0.19€ | -0.61€ | -0.33€ | 0.00€ |